Return to search results.
Complete title: A Phase 2, Open-Label Study of Rucaparib in Patients with Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
|Research Study Number||CO-338-017|
|Principal Investigator||Elizabeth Swisher, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Fallopian Cancer; Gynecological Cancer; Ovarian Cancer; Solid Tumors; Peritoneal Cancer, Primary (PPC)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.